history of glp-1 Reflections on the discovery as a satiety hormone: Implications for obesity therapy and future directions Frontiers | GLP-1R in diabetes

We found that removing germline disrupts the cell adhesions between GSC and DTC, causing a significant transcriptomic change in DTC through hmp-2/-catenin and two GATA transcription factors, elt-3 and pqm-1 in this niche cell

Final Thoughts Nausea on GLP-1 medications doesnt have to derail your weight-loss journey

The product information for all Glucagon-Like Peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists (dulaglutide, exenatide, liraglutide, semaglutide and tirzepatide) has been further updated to highlight the potential risk of severe acute pancreatitis with these products, including rare reports of necrotising and fatal pancreatitis

The GLP-1 market is poised for unprecedented growth over the next 5 years, presenting a unique opportunity for digital health behavioral change

The physiological actions of endogenou...

A pivotal moment occurred in October 2022, just four months after Mounjaros launch, when Elon Musk admitted on Twitter (X) that taking Wegovy was his secret for looking fit and healthy. The post, and a subsequent tweet in 2024 that he was taking Mounjaro, went viral and sparked widespread curiosity around GLP-1s and their effectiveness on weight loss